FXM Clinical Research Miami

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)1 trial
• Psoriasis1 trial
• Vitiligo1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Sun Pharmaceutical Industries Limited2 trials
• Pfizer1 trial

Running trials

• Active, not recruiting

  A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

  NCT06072183· Phase 3· Pfizer· Source

Closed trials

• Completed

  To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis

  NCT04684485· Phase 2· Sun Pharmaceutical Industries Limited· Source

• Completed

  To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis

  NCT04566666· Phase 2· Sun Pharmaceutical Industries Limited· Source